Clinical Trials for Juvenile Myelomonocytic Leukemia

Find clinical trials for juvenile myelomonocytic leukemia. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT ID: NCT03314974

This clinical trial is studying a type of treatment called allogeneic hematopoietic stem cell transplant (HCT) for patients with various blood cancers, including leukemia and lymphoma. The aim is t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

NCT ID: NCT03326921

This clinical trial is testing a new type of immunotherapy called HA-1 T cell therapy to treat patients with certain types of acute leukemia that have come back, are not responding to treatment, or...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT ID: NCT05800210

This clinical trial is investigating a new treatment approach for patients with certain types of blood cancers, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and vario...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gainesville, Florida, United States

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

NCT ID: NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial is a study designed to help doctors understand and treat different types of leukemia in children and young adults, especially when the leukemia ...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Lebanon, New Hampshire, United States +187 more

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

NCT ID: NCT03810196

This clinical trial is studying a new treatment approach for patients, particularly children and young adults under 25 years old, who have certain types of blood cancers like leukemia and lymphoma ...

Recruiting

Phase: NA Type: interventional Locations: Philadelphia, Pennsylvania, United States

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

NCT ID: NCT05735717

This clinical trial, titled "MT2021-08 T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies," is exploring a new treatment approach for patients with certain blood cancer...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation

NCT ID: NCT03843528

This clinical trial is studying a medication called vorinostat, which is being tested in combination with another drug, low-dose azacitidine, to see how well it can prevent the return of certain bl...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Petersburg, Florida, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions